These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8234695)

  • 1. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
    Yamashita Y; Torashima M; Takahashi M; Tanaka N; Katabuchi H; Miyazaki K; Ito M; Okamura H
    Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
    Hricak H; Finck S; Honda G; Göranson H
    AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
    Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
    Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal invasion by carcinoma of the cervix: assessment with dynamic MR imaging.
    Seki H; Azumi R; Kimura M; Sakai K
    AJR Am J Roentgenol; 1997 Jun; 168(6):1579-85. PubMed ID: 9168730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.
    Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Schaeffer U; Brix G; Essig M; Hoffmann U; Zuna I; Schönberg S; van Kaick G
    Radiology; 1996 Nov; 201(2):531-9. PubMed ID: 8888254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of the uterus: findings from high-resolution multisection dynamic imaging with a surface coil.
    Ito K; Fujita T; Uchisako H; Tanaka N; Matsui M; Tsukamoto K; Matsumoto T; Nakanishi T
    AJR Am J Roentgenol; 1994 Oct; 163(4):873-9. PubMed ID: 8092027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute stroke in cats: comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging.
    Maeda M; Itoh S; Ide H; Matsuda T; Kobayashi H; Kubota T; Ishii Y
    Radiology; 1993 Oct; 189(1):227-32. PubMed ID: 8372198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the effect of gonadotropin-releasing hormone (GnRH) analogue treatment on uterine leiomyomas based on MR imaging.
    Matsuno Y; Yamashita Y; Takahashi M; Katabuchi H; Okamura H; Kitano Y; Shimamura T
    Acta Radiol; 1999 Nov; 40(6):656-62. PubMed ID: 10598858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.
    Guthrie JA; Ward J; Robinson PJ
    Radiology; 1996 Nov; 201(2):347-51. PubMed ID: 8888221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
    Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
    Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR detection of degenerating uterine leiomyomas.
    Okizuka H; Sugimura K; Takemori M; Obayashi C; Kitao M; Ishida T
    J Comput Assist Tomogr; 1993; 17(5):760-6. PubMed ID: 8370831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
    Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
    AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of the normal and abnormal clivus.
    Kimura F; Kim KS; Friedman H; Russell EJ; Breit R
    AJR Am J Roentgenol; 1990 Dec; 155(6):1285-91. PubMed ID: 2122682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
    Nakahara H; Noguchi S; Murakami N; Tamura S; Jinnouchi S; Kodama T; Adjei ON; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
    Radiology; 1997 Mar; 202(3):765-72. PubMed ID: 9051032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
    Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
    Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
    Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
    J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced dynamic MR imaging of postmolar gestational trophoblastic disease.
    Yamashita Y; Torashima M; Takahashi M; Mizutani H; Miyazaki K; Matsuura K; Okamura H
    Acta Radiol; 1995 Mar; 36(2):188-92. PubMed ID: 7536014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging.
    Yamashita Y; Hatanaka Y; Yamamoto H; Arakawa A; Matsukawa T; Miyazaki T; Takahashi M
    Radiology; 1994 Oct; 193(1):59-65. PubMed ID: 8090922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment.
    Murase E; Siegelman ES; Outwater EK; Perez-Jaffe LA; Tureck RW
    Radiographics; 1999; 19(5):1179-97. PubMed ID: 10489175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T; Fujisawa H; Munechika H
    Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.